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Inflammasome Activation by
Propionibacterium acnes: The Story of
IL-1 in Acne Continues to Unfold
Diane M. Thiboutot1
Insights into the immune mechanisms at play in skin diseases including acne
continue to be made. In this issue, Kistowska et al. confirm that Propionibacter-
ium acnes activates inflammasomes leading to the production of IL-1b and they
further identify putative mechanisms by which this process occurs. These data
raise interesting questions regarding a multipronged approach by which P. acnes
elicits inflammation in early versus late acne and putative differences in the effects
of IL-1a and IL-1b in this disease process.
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Propionibacterium acnes is the predo-
minant organism in the microbiome of
facial skin (Grice et al., 2009). Although
thought to be commensal, P. acnes
exerts a variety of pro-inflammatory
activities most notable in patients with
acne vulgaris. This intriguing organism
orchestrates a multipronged approach to
trigger innate immunity in acne by
activating toll-like receptor 2 and, as
reported now, inflammasomes (Kim
et al., 2002; Kistowska et al., 2014;
Qin et al., 2014).
As reported in this issue, remarkable
convergence with respect to inflamma-
some activation by P. acnes has been
achieved (Kistowska et al., 2014; Qin
et al., 2014). Kistowska et al. (2014)
present a series of elegant experiments
that confirm and expand upon the
recent seminal findings of Qin et al.
(2014). Using a combination of in vitro
and in vivo assays, including inflamma-
some activation in monocytes, immuno-
histochemistry of inflammatory acne
lesions from patients, a mouse ear
model for P. acnes-induced inflam-
mation, and transgenic mouse models
of several defects in the inflammasome
pathway, Kistowska et al. (2014) con-
firm that P. acnes induces inflamma-
some activation in human monocytes
that is mediated by NLRP3 leading to
cleavage of pro-IL-1b to active IL-1b via
caspase 1. The authors demonstrate that
the release of IL-1b by monocytes in
response to P. acnes requires
phagocytosis, lysosomal damage with
release and activation of cathepsin B,
generation of reactive oxygen species,
and Kþ efflux as pointed out in their
recent commentary (Contassot and
French, 2014). Furthermore, they pro-
pose that IL-1b secreted from myeloid
cells in a NLRP3-inflammasome-depen-
dent manner, is responsible for the
induction of a neutrophilic inflamma-
tory response to P. acnes in vivo
(Kistowska et al., 2014).
In view of these advances, it becomes
even more compelling to examine how
and where P. acnes interacts with
immune cells (including keratinocytes)
in the distinct microenvironments of
early versus late acne lesions. This
question is relevant clinically in that
understanding the pro-inflammatory
actions of P. acnes in very early acne
may aid in identifying targets to suppress
early inflammation and thus to avoid
intensification of the inflammatory
response that follows follicular rupture.
Kistowska et al. (2014) injected P. acnes
into the dermis of the mouse ear to
model late stage acne. In the dermis,
P. acnes may be phagocytised by
myeloid cells, leading to inflamma-
some activation, secretion of IL-1b and
a neutrophilic response (Kistowska
et al., 2014). They conclude that mye-
loid cells are key players in inflamma-
some activation in acne.
In early acne, however, follicles are
surrounded by an infiltrate of lympho-
cytes and macrophages, and P. acnes is
contained within the intact follicle in
proximity to follicular keratinocytes
(Layton et al., 1998; Jeremy et al.,
2003). Very little is known about the
dynamics of myeloid cell infiltration
into follicles at this early stage. Toyoda
and Morohashi, (2001) published
electron micrographs depicting macro-
phages in close proximity to follicular
keratinocytes, but whether these were
early or late lesions and whether the
follicles were intact or disrupted were
not specified. Neutrophils were noted to
infiltrate the follicles and reach the
cornified layers, but it is uncertain
whether these neutrophils interacted
with P. acnes contained within the
follicles (Toyoda and Morohashi,
2001).
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Interaction of P. acnes with follicular
keratinocytes may be important in early
acne. Fifteen years ago, Guy and
Kealey, (1998a, b) demonstrated that
IL-1a leads to hyperkeratinization of
infundibular segments of follicles in a
fashion that is similar to what is seen in
the microcomedones of early acne.
Also, material extracted from come-
dones from acne patients demonstrated
high levels of IL-1a-like activity (Ingham
et al., 1992). Selway (2013) recently
used the organ culture model of Guy
and Kealey, (1998a, b) to demonstrate
that follicular keratinocytes secrete IL-1a
in response to peptidoglycan, a compo-
nent of the cell wall of P. acnes that
activates TLR2. These authors suggest
that TLR activation and secretion of IL-
1a from keratinocytes may be initiating
steps in comedogenesis and, therefore,
critical to the pathogenesis. Although
not examined in this study, it would be
very interesting to determine whether
P. acnes itself activates TLR2 on
follicular keratinocytes in this model.
Although studies demonstrate that
stimulation of keratinocytes by P. acnes
leads to secretion of IL-1a, there is
discordance in the literature concerning
this finding (Walters et al., 1995;
Ingham et al., 1998; Graham et al.,
2004; Nagy et al., 2005; Akaza et al.,
2009; Lee et al., 2010; Selway, 2013). A
summary of the published studies is
presented in Table 1. Akaza et al.
(2009) and Graham et al. (2004) report
that keratinocytes secrete IL-1a when
exposed to live or heat-killed P. acnes
in the stationary growth phase, but
studies by Ingham et al. (1998) and
Walters et al. (1995) do not. Of note is
that differences in P. acnes strains,
growth phases of the bacteria, use of
viable or killed P. acnes, differing
methods used to kill P. acnes, and
differences in use of P. acnes whole
cells, cellular components, or culture
supernatants may account for the
variations reported for IL-1a secretion
following P. acnes exposure. Close
examination of the experimental details
of earlier studies reveals several
plausible explanations for the differing
results. We now know that P. acnes
activates TLR2 on keratinocytes leading
to cytokine production, and that the
P. acnes proteins responsible for TLR
activation are associated with the cell
wall. In the studies by Walters et al.
(1995) and Ingham et al. (1998), the cell
wall fraction of P. acnes was discarded,
and the keratinocytes were exposed to
intracellular fractions of P. acnes, which
would decrease the likelihood of TLR2
activation. Also in these studies and in
one experiment reported by Graham
et al. (2004), P. acnes was inactivated
using formaldehyde, which again may
alter the surface proteins of P. acnes and
blunt the ability of the organism to
activate TLR2 on keratinocytes.
Kistowska et al. (2014) demonstrate
that keratinocytes are unable to secrete
mature IL-1b following exposure to one
strain of heat-killed P. acnes. Additional
experimental details, such as the growth
phase of the organism, would be helpful
in interpreting this finding. It would also
be important to conduct these experi-
ments using additional strains of P. acnes
before drawing the general conclusion
that P. acnes is unable to stimulate IL-1b
secretion in keratinocytes.
Clinical Implications
 Remarkable convergence appears to have been achieved regarding
inflammasome activation by Propionibacterium acnes.
 The work reported by Kistowska et al. confirms and extends the conclu-
sion that P. acnes activates inflammasomes, leading to IL-1b release, most
likely within the dermis.
 This work offers prospects for novel therapies to be directed against
inflammatory acne.
Table 1. Effect of P. acnes on keratinocyte expression or secretion of IL-1a
Study P. acnes strain(s) Growth phase P. acnes component Viability IL-1a
Ingham et al., 1998 Clinical isolate 48-h Stationary Intracellular soluble cell
fraction
Sheared cells (cell wall
fraction removed)
ELISA ( )
Walters et al., 1995 Clinical isolate 48-h Stationary Whole cell Formaldehyde-killed ELISA ( )
Culture supernatant ELISA ( )
Intracellular soluble cell
fraction
Sheared cells (cell wall
fraction removed)
ELISA ( )
Graham et al., 2004 P37 24-h Exponential Whole cell Live ELISA ( )
Formaldehyde-killed ELISA ( )
Graham et al., 2004 P37 48-h Stationary Whole cell Live ELISA (þ )
Formaldehyde-killed ELISA ( )
Nagy et al., 2005 889,2005,6609 ATCC
11828
48-h Stationary Whole cell Live mRNA ( )
Akaza et al., 2009 JCM 6425 48-h Stationary Whole cell Live ELISA (þ )
JCM 6473 5 clinical
isolates
Heat-killed All strains and all
viabilities
Lee et al., 2010 ATCC 6919 24-h Exponential Culture supernatant mRNA (þ )
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Despite the fact that acne may be the
most common skin disease, it is clear
that there are missing pieces in its puz-
zling pathogenesis. This excellent work
by Kistowska et al. (2014) validates the
recent work of Qin et al. (2014) and
takes the field one step closer to
understanding the immunologic
mechanisms at play in acne. Important
next steps would be to examine the
mechanisms by which P. acnes
activates the innate immune response
within the unique microenvironments
that arise during acne lesion develop-
ment and to examine the respective
roles of IL-1a and IL-1b in this process.
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The Adverse Effect of IFN Gamma on
Stratum Corneum Structure and
Function in Psoriasis and Atopic
Dermatitis
Kenneth R. Feingold1
There is a marked increase in cytokines, including interferon gamma, in cutaneous
diseases such as atopic dermatitis and psoriasis. In this issue of the Journal,
Tawada and colleagues demonstrate that the quantity of ultra long–chain
ceramides in the stratum corneum, which play a key role in maintaining the
permeability barrier, is reduced in atopic dermatitis and psoriasis. Further, they
demonstrate that interferon gamma decreases the expression of the enzymes
required for the synthesis of these ultra long–chain ceramides (ELOVLs and
ceramide synthase 3). These results suggest that an increase in interferon gamma
by decreasing the key enzymes required for the synthesis of ultra long–chain
ceramides could further impair permeability barrier function, thereby exacerbat-
ing the pathological changes.
Journal of Investigative Dermatology (2014) 134, 597–600. doi:10.1038/jid.2013.440
It has long been recognized that cyto-
kines, such as tumor necrosis factor
(TNF), IL-1, IL-6, and the IFNs, regulate
lipid metabolism (Hardardottir et al.,
1994; Khovidhunkit et al., 2004).
Studies in the 1980s demonstrated that
TNF and other cytokines would inhibit
fat accumulation in adipocytes by
decreasing the activity of lipoprotein
lipase and by inhibiting fatty acid
synthesis. In contrast, in the liver, TNF
and other cytokines stimulate lipid
synthesis and VLDL production, which
contributes to the elevation in serum
triglyceride levels that characteristically
occurs during infections and inflam-
matory diseases. Over the ensuing
years, cytokines have been shown to
affect a large number of different lipid
metabolic pathways in a wide variety
of tissues (Hardardottir et al., 1994;
Khovidhunkit et al., 2004). Not surpri-
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